ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Benefits Of Implementing EDC & Medical Coding With RTSM

  Discover what happened when the Fountayn Platform, including RTSM, was used to support a client’s two-year, Phase III study seeking a cure for multiple sclerosis.

• The Role Of AI Throughout The Clinical Research Journey

  AI revolutionizes clinical trials by optimizing study design, automating processes, enhancing patient-centric approaches, and providing real-time insights.

• Are You Aiming For The Bullseye Or Just The Target?

  Learn what this author has to say about focusing on a clinical trial's outcome when developing Risk-Based Quality Management strategies.

• From Imaging To Analysis: 5 Steps For Success With TrialKit PACS

  Obtain a fully integrated platform that seamlessly connects imaging data with EDC systems, resulting in streamlined data acquisition, real-time collaboration, and advanced analysis within a unified system.

• Five Ways Site-Facing Technology Helps Sponsors And CROs

  Site-facing technology is presented as a crucial enabler of efficient trial execution, aligning site operations with sponsor timelines and objectives.

• Regulatory Guidance For PRO Strategy In Oncology Trials

  Kelly Dumais, Principal Scientific Advisor, and Jowita Marszewska, Scientific Advisor at Clario eCOA, delve into the specifics of how recent regulatory advancements are influencing PRO Strategy.

• AI-Powered Breakthroughs In CNS And Pain Trials

  Discover how AI-powered tools like EEG are revolutionizing neurological and pain clinical trials by replacing subjectivity with precision and drastically accelerating the path to approval.

• How Automated Site Payment Solutions Are Revolutionizing Clinical Trials

  Discover how a specialized site payment solution can streamline your clinical trials, enhance site engagement, and deliver measurable financial benefits.

• Data-Driven Physician Engagement For Ultra-Rare Diseases

  How can an effective partnership help you to utilize advanced data analytics to address the significant challenges of clinical trials centered around ultra-rare diseases?

• Harnessing The Power of Real-World Data In Clinical Trial Planning

  As the availability of RWD grows, it creates opportunities for sponsors to use true patient insights to support their clinical strategy and bring treatments to patients in need.